Anti-VMAT2/ SLC18A2/ PKDYS2 monoclonal antibody

Anti-VMAT2/ SLC18A2/ PKDYS2 antibody for FACS & in-vivo assay

Target products collectionGo to SLC18A2/SLC18A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T48873-Ab-1/ GM-Tg-hg-T48873-Ab-2Anti-Human SLC18A2 monoclonal antibodyHuman
GM-Tg-rg-T48873-Ab-1/ GM-Tg-rg-T48873-Ab-2Anti-Rat SLC18A2 monoclonal antibodyRat
GM-Tg-mg-T48873-Ab-1/ GM-Tg-mg-T48873-Ab-2Anti-Mouse SLC18A2 monoclonal antibodyMouse
GM-Tg-cynog-T48873-Ab-1/ GM-Tg-cynog-T48873-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC18A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T48873-Ab-1/ GM-Tg-felg-T48873-Ab-2Anti-Feline SLC18A2 monoclonal antibodyFeline
GM-Tg-cang-T48873-Ab-1/ GM-Tg-cang-T48873-Ab-2Anti-Canine SLC18A2 monoclonal antibodyCanine
GM-Tg-bovg-T48873-Ab-1/ GM-Tg-bovg-T48873-Ab-2Anti-Bovine SLC18A2 monoclonal antibodyBovine
GM-Tg-equg-T48873-Ab-1/ GM-Tg-equg-T48873-Ab-2Anti-Equine SLC18A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T48873-Ab-1/ GM-Tg-hg-T48873-Ab-2; GM-Tg-rg-T48873-Ab-1/ GM-Tg-rg-T48873-Ab-2;
GM-Tg-mg-T48873-Ab-1/ GM-Tg-mg-T48873-Ab-2; GM-Tg-cynog-T48873-Ab-1/ GM-Tg-cynog-T48873-Ab-2;
GM-Tg-felg-T48873-Ab-1/ GM-Tg-felg-T48873-Ab-2; GM-Tg-cang-T48873-Ab-1/ GM-Tg-cang-T48873-Ab-2;
GM-Tg-bovg-T48873-Ab-1/ GM-Tg-bovg-T48873-Ab-2; GM-Tg-equg-T48873-Ab-1/ GM-Tg-equg-T48873-Ab-2
Products NameAnti-SLC18A2 monoclonal antibody
Formatmab
Target NameSLC18A2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC18A2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species VMAT2/ SLC18A2/ PKDYS2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP000771human SLC18A2 Lentivirus plasmid
    ORF Viral VectorvGMLP000771human SLC18A2 Lentivirus particle
    ORF Viral VectorpGMLPm003030mouse Slc18a2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003030mouse Slc18a2 Lentivirus particle


    Target information

    Target IDGM-T48873
    Target NameSLC18A2
    Gene ID6571,214084,25549,701133,486908,101086507,282471,100058805
    Gene Symbol and Synonyms1110037L13Rik,9330105E13,MNAT,PKDYS2,SLC18A2,SVAT,SVMT,VAT2,VMAT-2,VMAT2
    Uniprot AccessionQ05940,Q01827,Q27963
    Uniprot Entry NameVMAT2_HUMAN,VMAT2_RAT,VMAT2_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000165646
    Target ClassificationN/A

    The target: SLC18A2, gene name: SLC18A2, also named as PKDYS2, SVAT, SVMT, VAT2, VMAT2. This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.